Zenith Healthcare Ltd
BSE:530665
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| IN |
|
Zenith Healthcare Ltd
BSE:530665
|
180m INR |
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
993.1B USD |
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
587B USD |
Loading...
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
286.3B CHF |
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
235.3B GBP |
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
239B CHF |
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
304.3B USD |
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK |
Loading...
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD |
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
158.1B USD |
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
123.7B USD |
Loading...
|
Market Distribution
| Min | -153 833.3% |
| 30th Percentile | 2.7% |
| Median | 7.3% |
| 70th Percentile | 13.2% |
| Max | 9 977% |
Other Profitability Ratios
Zenith Healthcare Ltd
Glance View
Zenith Healthcare Ltd. engages in the manufacture of pharmaceuticals formulation in the forms of tablets, capsules, oral liquids and injections. The company is headquartered in Ahmedabad, Gujarat. The firm offers its products across various therapeutic segments, including antibiotics and anti-infective, gastrointestinal tract, analgesic/anti-inflammatory, cardiovascular system, respiratory, ophthalmology, bio-technical products, oncology, anti-retroviral, central nervous system, nutrition, genito urinary system and skin. Its products across antibiotics and anti-infective category includes Roxythromycin Tablets, Ciprofloxacin Tablets, Azithromycine Dihydrate Suspension and Azithromycin Oral Suspension. Its product across gastrointestinal category includes Ranitidine Hydrochloride Tablets. Its product across cardiovascular system includes Lisinopril Tablets. Its products across analgesic category include Paracetamol and Aceclofenac Tablets. The company offers contract manufacturing of all dosage forms.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for Zenith Healthcare Ltd is -3.6%, which is below its 3-year median of -1.4%.
Over the last 3 years, Zenith Healthcare Ltd’s Operating Margin has decreased from 0.5% to -3.6%. During this period, it reached a low of -3.6% on Sep 30, 2025 and a high of 0.5% on Sep 30, 2022.
